SIFI recibe opinión positiva de COMP sobre la designación de medicamento huérfano para la polihexanida

SIFI S.p.A. Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

View original content:https://www.prnewswire.com/news-releases/sifi-recibe-opinion-positiva-de-comp-sobre-la-designacion-de-medicamento-huerfano-para-la-polihexanida-302202528.html